Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Simris Alg AB's book value per share for the quarter that ended in Mar. 2026 was €0.00.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Simris Alg AB was 47.30% per year. The lowest was -61.10% per year. And the median was -42.65% per year.
Simris Alg AB's current price is €0.0056. Its book value per share for the quarter that ended in Mar. 2026 was €0.00. Hence, today's PB Ratio of Simris Alg AB is .
During the past 12 years, the highest P/B Ratio of Simris Alg AB was 41.83. The lowest was 0.61. And the median was 2.47.
Warning Sign:
Simris Alg AB stock PB Ratio (=29.63) is close to 1-year high of 29.63.
Simris Alg AB (FRA:5LU) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Simris Alg AB Book Value per Share Related Terms
Simris Alg AB Book Value per Share Historical Data
* Premium members only.
The historical data trend for Simris Alg AB's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:5LU vs VRTX, REGN, ALNY: Book Value per Share Comparison
For the Biotechnology subindustry, Simris Alg AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Simris Alg AB PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Simris Alg AB's PB Ratio distribution charts can be found below:
* The bar in red indicates where Simris Alg AB's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Simris Alg AB (FRA:5LU) has a Book Value per Share of €0.00 as of Mar. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Simris Alg AB and its competitors.
Is Simris Alg AB's Book Value per Share too high?
Simris Alg AB's current Book Value per Share is €0.00. Overall, Simris Alg AB has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Simris Alg AB's Book Value per Share compare to VRTX and REGN?
Simris Alg AB's Book Value per Share of €0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Biotechnology company?
A good Book Value per Share depends on the Biotechnology industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Simris Alg AB and its competitors. Simris Alg AB's current Book Value per Share is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simris Alg AB stock overvalued right now?
Simris Alg AB (FRA:5LU) has a current Book Value per Share of €0.00. The current Book Value per Share is €0.00. Simris Alg AB's overall GF Score™ is 19/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Simris Alg AB (FRA:5LU), the current Book Value per Share is €0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Simris Alg AB is a biotechnology company, engaged in research, development and production of bioactive substances from microalgae, for nutraceutical, cosmeceutical and pharmaceutical applications. The company's technology provides access to bioactive substances with novel functions, while replacing unsustainable raw materials from endangered marine species and ecosystems. Its first commercialised range is a series of omega-3 health supplements marketed under the company's own brand.
19GF Score
Get the complete analysis for FRA:5LU
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5LU has been successfully added to your 
